Prediction of extracapsular extension of prostate cancer based on systematic core biopsies

Scandinavian Journal of Urology and Nephrology

Volumn 40, Issue 6, 2006, Pages 459-464

  Tarjan M ^a   Tot, T ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Extracapsular extension; Large section technique; Prostate biopsy; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; GLEASON SCORE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

AGED; BIOPSY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 33751558452     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590600795446     Document Type: Article

References (25)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
2. Stamey TA, Donaldson AN, Yemoto CE, McNeal JE, Sozen S, Gill H. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. J Urol 1998;160:2412-7.
3. Bahn DK, Lee F. Cryosurgical ablation therapy for prostate cancer. Arch Ital Urol Androl 2000;72:302-4.
4. Kiel HJ, Wieland WF, Rossler W. Local control of prostate cancer by transrectal HIFU-therapy. Arch Ital Urol Androl 2000;72:313-9.
5. Gancarczky KJ, Wu H, McLeod DG, Kane C, Kusuda L, Lance R, et al. Using the percentage of biopsy cores positive for cancer, pre-treatment PSA and highest biopsy Gleason sum to predict pathology stage after radical prostatectomy: The Center for Prostate Disease Research nomograms. Urology 2003;61:589-95.
6. King CR, Patel DA, Terris MK. Prostate biopsy volume indices do not predict for significant Gleason upgrading. Am J Clin Oncol 2005;28:125-9.
7. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-24.
8. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997;277:1445-51.
9. Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol 2001;163:174-8.
10. Cheng L, Slezak J, Bregstrall EJ, Myers RP, Zincke H, Bostwick DG. Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy. J Clin Oncol 2000;18:2862-8.
11. Bostwick DG, Qian J, Bergstrall EJ, Dundore P, Dugan J, Myers RP, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155:1361-7.
12. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol 1988;139:1235-41.
13. Lorentzen T, Nerstrom H, Iversen P, Torp-Pedersen ST. Local staging of prostate cancer with transrectal ultrasound: a literature review. Prostate Suppl 1992;4:11-6.
14. Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-T2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990;144:1180-4.
15. Paulson DF. Impact of radical prostatectomy in management of clinically localized disease. J Urol 1994;152:1826-30.
16. Grossfeld GD, Chang JJ, Boering JM, Li YP, Lubeck DP, Flanders SC, et al. Understaging and undergrading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol 2001;165:851-6.
17. Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV. Patient selection for prostate monotherapy. Int J Radiat Oncol Phys 2001;49:673-7.
18. Ogawa O, Egawa S, Arai Y, Tolisu K, Yoshida O, Kato T. Preoperative predictors for organ confined disease in Japanese patients with stage T1c prostate cancer. Int J Urol 1998;5:454-8.
19. Gohji K, Okamoto M, Takenaka A, Nomi M, Fujii A. Predicting the extent of prostate cancer using the combination of systematic biopsy and serum prostate specific antigen in Japanese men. BJU Int 1999;83:39-42.
20. Peller PA, Young DC, Marmaduke DP, Marsh WL. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy. Cancer 1995;75:530-8.
21. Tigrani VS, Bhargava V, Sinohara K, Presti JC Jr. Number of positive systematic sextant biopsies predicts surgical margin status at radical prostatectomy. Urology 1999;54:689-93.
22. Amin M, Boccon-Gibod L, Egevad L, Epstein JI, Humphrey PA, Mikuz G, et al. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. Scand J Urol Nephrol Suppl 2005;216:20-33.
23. Ohori M, Kattan MW, Koh H, Maru N, Slawin KM, Shariat S, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004;171:1844-9.
24. Haese A, Epstein JI, Huland H, Partin AW. Validation of biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 2002;95:1016-21.
25. Conrad S, Graefen M, Pichlmeier U, Henke RP, Mammerer PG, Huland H. Systematic sextant biopsies improve preoperative prediction of pelvic lymph node metastases in patients with clinically localized prostatic carcinoma. J Urol 1998;159:2023-9.